AR066664A1 - Un medicamento para tratar enfermedad de alzheimer - Google Patents
Un medicamento para tratar enfermedad de alzheimerInfo
- Publication number
- AR066664A1 AR066664A1 ARP080102154A ARP080102154A AR066664A1 AR 066664 A1 AR066664 A1 AR 066664A1 AR P080102154 A ARP080102154 A AR P080102154A AR P080102154 A ARP080102154 A AR P080102154A AR 066664 A1 AR066664 A1 AR 066664A1
- Authority
- AR
- Argentina
- Prior art keywords
- disease
- salts
- medicinal product
- treat alzheimer
- medicament
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical compound O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- -1 1-cyclohexyl-1H-tetrazol-5- yl Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229960003530 donepezil Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007135367 | 2007-05-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR066664A1 true AR066664A1 (es) | 2009-09-02 |
Family
ID=39636992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102154A AR066664A1 (es) | 2007-05-22 | 2008-05-21 | Un medicamento para tratar enfermedad de alzheimer |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20100298375A1 (enExample) |
| EP (2) | EP2937085B1 (enExample) |
| JP (1) | JP5153870B2 (enExample) |
| KR (1) | KR101441725B1 (enExample) |
| CN (1) | CN101754758B (enExample) |
| AR (1) | AR066664A1 (enExample) |
| AU (1) | AU2008253977B2 (enExample) |
| BR (1) | BRPI0811919A2 (enExample) |
| CA (1) | CA2687289C (enExample) |
| CO (1) | CO6251249A2 (enExample) |
| CY (1) | CY1116683T1 (enExample) |
| DK (1) | DK2157973T3 (enExample) |
| ES (1) | ES2545959T3 (enExample) |
| HR (1) | HRP20150843T1 (enExample) |
| HU (1) | HUE025902T2 (enExample) |
| IL (1) | IL202053A (enExample) |
| MX (1) | MX2009012583A (enExample) |
| MY (1) | MY146407A (enExample) |
| NZ (1) | NZ581099A (enExample) |
| PL (1) | PL2157973T3 (enExample) |
| PT (1) | PT2157973E (enExample) |
| RU (1) | RU2469723C2 (enExample) |
| SI (1) | SI2157973T1 (enExample) |
| TW (2) | TWI423802B (enExample) |
| UA (1) | UA96633C2 (enExample) |
| WO (1) | WO2008143361A1 (enExample) |
| ZA (1) | ZA200908202B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2135607A1 (en) | 2008-06-18 | 2009-12-23 | Pharnext | Combination of pilocarpin and methimazol for treating Charcot-MarieTooth disease and related disorders |
| US9387206B2 (en) | 2009-11-03 | 2016-07-12 | Pharnext | Therapeutic approaches for treating Alzheimer's disease |
| EP2322163A1 (en) * | 2009-11-03 | 2011-05-18 | Pharnext | New therapeutics approaches for treating alzheimer disease |
| SI2560631T1 (sl) | 2011-03-01 | 2014-06-30 | Pharnext | Na baklofenu in akamprosatu temeljeäśa terapija nevroloĺ kih nepravilnosti |
| US9241933B2 (en) | 2011-03-01 | 2016-01-26 | Pharnext | Compositions for treating amyotrophic lateral sclerosis |
| US10010515B2 (en) | 2011-03-01 | 2018-07-03 | Pharnext | Therapeutic approaches for treating Parkinson's disease |
| US9248111B2 (en) | 2011-03-01 | 2016-02-02 | Pharnext | Therapeutic approaches for treating parkinson's disease |
| MX2014015310A (es) | 2012-06-15 | 2015-07-06 | Found Biomedical Res & Innov | Agente profilactico y/o terapeutico para el deterioro cognoscitivo leve. |
| WO2015100255A2 (en) * | 2013-12-23 | 2015-07-02 | Holaday John W | Disposable container for air hydration |
| CN109310688B (zh) | 2016-05-19 | 2023-09-01 | 国立研究开发法人国立循环器病研究中心 | 用于预防和/或治疗痴呆症的药物 |
| HUE053636T2 (hu) | 2017-05-24 | 2021-07-28 | H Lundbeck As | 5-HT6 receptor antagonista és acetilkolin-észteráz inhibitor kombinációja Alzheimer-kór kezelésében történõ alkalmazásra ApoE4 alléleket hordozó betegek szubpopulációjában |
| CN107602523B (zh) * | 2017-09-11 | 2020-08-18 | 安徽中医药大学 | 京尼平类似物、制备方法及其应用 |
| PL237739B1 (pl) | 2018-06-06 | 2021-05-17 | Univ Gdanski | Genisteina do zastosowania do leczenia choroby Alzheimera |
| NL2024431B1 (en) | 2019-12-11 | 2021-09-07 | Sulfateq Bv | Compounds for treatment of alzheimer’s disease |
| CN117797095A (zh) * | 2023-11-30 | 2024-04-02 | 浙江大学 | 一种长效脂质液晶植入物及其治疗阿尔茨海默症的用途 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5535019A (en) * | 1978-09-01 | 1980-03-11 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| JPS5649378A (en) | 1979-08-25 | 1981-05-02 | Otsuka Pharmaceut Co Ltd | Tetrazolylalkoxycarbostyril derivative |
| FI95572C (fi) | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| JP2574099B2 (ja) | 1992-05-21 | 1997-01-22 | 大塚製薬株式会社 | アレルギー疾患治療剤 |
| JPH10175864A (ja) | 1996-12-16 | 1998-06-30 | Otsuka Pharmaceut Co Ltd | 慢性閉塞性肺疾患治療剤 |
| US6428488B1 (en) * | 1997-08-28 | 2002-08-06 | Kenneth Kensey | Dual riser/dual capillary viscometer for newtonian and non-newtonian fluids |
| US6322525B1 (en) * | 1997-08-28 | 2001-11-27 | Visco Technologies, Inc. | Method of analyzing data from a circulating blood viscometer for determining absolute and effective blood viscosity |
| US6019735A (en) * | 1997-08-28 | 2000-02-01 | Visco Technologies, Inc. | Viscosity measuring apparatus and method of use |
| US6322524B1 (en) * | 1997-08-28 | 2001-11-27 | Visco Technologies, Inc. | Dual riser/single capillary viscometer |
| WO1999036405A1 (en) * | 1998-01-16 | 1999-07-22 | Eisai Co., Ltd. | Process for production of donepezil derivative |
| US6187790B1 (en) * | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
| US6484565B2 (en) * | 1999-11-12 | 2002-11-26 | Drexel University | Single riser/single capillary viscometer using mass detection or column height detection |
| US6458804B1 (en) * | 2001-01-26 | 2002-10-01 | R.T. Alamo Venturesi, Llc | Methods for the treatment of central nervous system disorders in certain patient groups |
| TW200301135A (en) * | 2001-12-27 | 2003-07-01 | Otsuka Maryland Res Inst Inc | Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| IL150509A (en) * | 2002-07-01 | 2007-07-04 | Joseph Kaspi | Pharmaceutical preparations containing donafazil hydrochloride |
| US6743806B2 (en) * | 2002-10-23 | 2004-06-01 | Otsuka Pharmaceutical Company, Limited | Active oxygen scavenger |
| FR2848452B1 (fr) * | 2002-12-12 | 2007-04-06 | Aventis Pharma Sa | Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer |
| JP2004189706A (ja) * | 2002-12-13 | 2004-07-08 | Eisai Co Ltd | 高度アルツハイマー型痴呆治療剤 |
| TWI323660B (en) * | 2003-02-25 | 2010-04-21 | Otsuka Pharma Co Ltd | Pten inhibitor or maxi-k channels opener |
-
2008
- 2008-05-21 TW TW097118634A patent/TWI423802B/zh not_active IP Right Cessation
- 2008-05-21 AR ARP080102154A patent/AR066664A1/es unknown
- 2008-05-21 CN CN2008800167568A patent/CN101754758B/zh not_active Expired - Fee Related
- 2008-05-21 EP EP15164200.6A patent/EP2937085B1/en active Active
- 2008-05-21 TW TW102147146A patent/TWI489983B/zh not_active IP Right Cessation
- 2008-05-21 CA CA2687289A patent/CA2687289C/en not_active Expired - Fee Related
- 2008-05-21 ES ES08764779.8T patent/ES2545959T3/es active Active
- 2008-05-21 JP JP2010509026A patent/JP5153870B2/ja not_active Expired - Fee Related
- 2008-05-21 DK DK08764779.8T patent/DK2157973T3/en active
- 2008-05-21 KR KR1020097026651A patent/KR101441725B1/ko not_active Expired - Fee Related
- 2008-05-21 HR HRP20150843TT patent/HRP20150843T1/hr unknown
- 2008-05-21 NZ NZ581099A patent/NZ581099A/en not_active IP Right Cessation
- 2008-05-21 PT PT87647798T patent/PT2157973E/pt unknown
- 2008-05-21 UA UAA200913247A patent/UA96633C2/uk unknown
- 2008-05-21 MX MX2009012583A patent/MX2009012583A/es active IP Right Grant
- 2008-05-21 AU AU2008253977A patent/AU2008253977B2/en not_active Ceased
- 2008-05-21 BR BRPI0811919-8A2A patent/BRPI0811919A2/pt not_active IP Right Cessation
- 2008-05-21 US US12/599,962 patent/US20100298375A1/en not_active Abandoned
- 2008-05-21 SI SI200831493T patent/SI2157973T1/sl unknown
- 2008-05-21 EP EP08764779.8A patent/EP2157973B1/en not_active Not-in-force
- 2008-05-21 PL PL08764779T patent/PL2157973T3/pl unknown
- 2008-05-21 MY MYPI20094815A patent/MY146407A/en unknown
- 2008-05-21 RU RU2009147456/15A patent/RU2469723C2/ru not_active IP Right Cessation
- 2008-05-21 WO PCT/JP2008/059763 patent/WO2008143361A1/en not_active Ceased
- 2008-05-21 HU HUE08764779A patent/HUE025902T2/en unknown
-
2009
- 2009-11-11 IL IL202053A patent/IL202053A/en not_active IP Right Cessation
- 2009-11-20 ZA ZA200908202A patent/ZA200908202B/xx unknown
- 2009-12-21 CO CO09145995A patent/CO6251249A2/es active IP Right Grant
-
2015
- 2015-09-14 CY CY20151100797T patent/CY1116683T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6251249A2 (es) | Un medicamento que comprende un derivado un derivado de carbostirilo y donepezilo para tratar enfermedad de alzheimer | |
| CR20120289A (es) | Derivados de dioxa-biciclo[3.2.1]octano-2,3,4-triol | |
| CO6480931A2 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas. | |
| DOP2014000243A (es) | Compuesto heterocíclico nitrogenado | |
| MX353752B (es) | Los ácidos sórbico y benzoico y sus derivados aumentan la actividad de un neurofármaco. | |
| BR112014008686A2 (pt) | derivados de oxazina e uso dos mesmos no tratamento de doença | |
| CO6480932A2 (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida. | |
| CU20120015A7 (es) | Piridina y pirazina como derivados de moduladores de la proteína kinasa | |
| UY32848A (es) | Compuestos heterocíclicos de oxima | |
| UY32502A (es) | Agentes antihelmínticos y su utilización | |
| UY30835A1 (es) | 8-alquinilxantinas y derivados | |
| CO2020000240A2 (es) | Combinación que comprende palbociclib y ácido 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxílico | |
| CY1112233T1 (el) | Παραγωγα 1,2,3-τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης | |
| CO6460766A2 (es) | Compuestos de haloalquil heteroaril benzamida | |
| SV2011003855A (es) | Heteroarilos sustituidos | |
| AR059027A1 (es) | Administracion de inhibidores de dipeptidil peptidasa | |
| UY31526A1 (es) | 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso | |
| BR112017009647A2 (pt) | 2-amino-3,5-difluoro-3,6-dimetil-6-fenil-3,4,5,6-tetraidropiridinas como inibidoras da bace1 para tratar a doença de alzheimer | |
| AR090241A1 (es) | INHIBIDORES DE LA b-SECRETASA | |
| MX2020005735A (es) | Derivados de glutarimida, uso de los mismos, composición farmacéutica basada en los mismos y métodos para producir derivados de glutarimida. | |
| UY31305A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen. | |
| AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
| AR067446A1 (es) | Un medicamento para tratar higado graso que comprende cilostazol | |
| AR114032A2 (es) | 5-(3,4-dicloro-fenil)-n-(2-hidroxi-ciclohexil)-6-(2,2,2-trifluor-etoxi)-nicotinamida y sales de la misma | |
| BR112015023013A2 (pt) | inibidores de quinase cdk9 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |